Navigation Links
Altogen Labs Offers New Pre-Clinical CRO Services to Accelerate Pre-Clinical Research Needs
Date:4/26/2013

Austin, TX (PRWEB) April 26, 2013

Altogen Labs, a biotechnology company focused on providing biotechnology research services for pharmaceutical, biotechnology, and academic institutions worldwide, today announced addition of new pre-clinical contract research services enabling companies to accelerate pre-clinical research needs.

Pre-clinical trials assess the toxicity and pharmacological activity of investigative new drugs (INDs) to assess a compound’s therapeutic potential and safety for human use. A very important component of pre-clinical trials includes in vivo toxicology analysis. At Altogen Labs, in vivo toxicology studies can include acute, subchronic, and chronic toxicity tests to study of toxic effects of chemical substances.

Altogen Labs provides following in vivo services for efficacy studies in the drug discovery phase: rodent xenograft models, teratoma formation and analysis services, cancer disease animal models, in vivo siRNA delivery and tissue targeting, pharmacokinetics (PK) and pharmacodynamics (PD) services, immune response and biomarker analysis.

To accelerate the development of new anti-cancer medicines, Altogen Labs offers in vivo xenograft services for drug development studies to treat inflammation, infectious diseases, cancer, pain, immunology and obesity. As a GLP-compliant laboratory, animal handling is IACUC-regulated and in accordance with FDA regulations. A variety of disease models are now available for testing.

Altogen Labs excels in providing excellent preservation and maintenance of cell banks. Cell viability is ensured by our redundant backup system in our secure, monitored and controlled storage facility. Cell banking services include maintenance and around the clock monitoring of cell bank environments, providing clients with cell lines free of bacterial and mycoplasma contamination.

Altogen Labs, also provides generation of stable cell line services from start to finish. The development of stable cell lines is a necessity to science today and provides researchers with the ability to design, create, and characterize stable cell lines that express a gene of interest. Although this process is time consuming, at Altogen Labs the generation of stable cell lines can take as little as 6-12 weeks.

By offering RNA Interference (RNAi) services, Altogen Labs provide clients with RNAi gene silencing in vivo and in vitro services from beginning to end. These RNAi services include the design and development of in vivo stable siRNA, shRNA, and microRNA, tissue targeting and stable RNAi knockdown cell line development, siRNA library screening, RNAi delivery, development of in vivo siRNA transfection reagents and kits, qPCR quantification of mRNA knockdown or amplification effects, in vitro functional testing, and gene targeting.

About Altogen Labs

Altogen Labs is a contract research organization (CRO) providing biotechnology research services for pharmaceutical, biotechnology, and academic institutions worldwide. Altogen Labs services include skilled laboratory CRO pre-clinical research, including generation of stable cell lines and tissue culture compound testing services, in vivo toxicology studies for IND applications, biodistribution studies and xenograft animal models, gene expression analysis, as well as tissue-targeted in vivo RNAi and siRNA delivery services. Altogen Labs is headquartered in Austin, TX. For more information, please visit AltogenLabs.com, e-mail info(at)altogenlabs(dot)com, or call us 512-433-6177.

Read the full story at http://www.prweb.com/releases/2013/4/prweb10674479.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Altogen Labs Announces Patent Filing for Bioremediation Process and Oil Spill Cleanup Products
2. Probiotic Action Offers New Ways to Stay Germ Free at the Gym
3. Bed Bugs Hit Another Apartment Complex, My Cleaning Products Says Non-Pesticide Bed Bug Spray Makes the Better Elimination Help and Offers Samples of It
4. Dr. Vasquez at the Connecticut Plastic Surgery Group Now Offers the Unique Crisalix 3D Simulations for Facial Aesthetics and Breast Augmentation
5. Bed Bugs Prompt Fire Departments to Develop New Policy, My Cleaning Products Offers Pesticide-Exempt Bed Bug Spray Samples to Help the Bed-Bug-Affected Fire Stations
6. Mississippi Storm Leaves State Devastated, My Cleaning Products Offers Samples of Its Mold Sprays to Help Residents with the Expected Mold Problem
7. Bed Bugs Invade Senior Housing Complex, My Cleaning Products Offers Residents Samples of Its Non-Pesticide Bed Bug Spray as Aid
8. Probiotic Action Announces New Insight on Why Acne is a Problem for First World Citizens and Offers Advice on Treatments
9. My Cleaning Products Reveals Nelson Castro Once Sponsored a Bed Bug Bill, Offers Samples of Non-Pesticide Bed Bug Spray
10. Mold Plagues New Florida Home Owners, Environmental Impact Assessment Company AGC Environmental Offers Them Insights on Obtaining Expert Mold Remediation and Inspection
11. A Long-Awaited Mouse Offers a New Animal Model for FSH Muscular Dystrophy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the "Company") (TSX-V: SQD; ... three months ended December 31, 2016. SQI ... diagnostics company that develops and commercializes proprietary technologies and products ... ... commercial milestones achieved in fiscal 2016," said Andrew Morris ...
(Date:2/21/2017)... ... ... The medical potential of stem cells is both extensive and astounding, and ... their differentiating characteristics. Stem cells are unique as the have the potential to renew ... tissue or organic-specific cells with special functions. , Stem cell therapy in the ...
(Date:2/21/2017)... 21, 2017  Lexus, a returning partner of the Amgen ... and exclusive automobile partner of the men,s and women,s events for ... The 2017 Amgen Tour of California will ... of the best professional cycling teams in the world racing from ... four-day Amgen Breakaway from Heart Disease TM Women,s ...
(Date:2/20/2017)... (PRWEB) , ... February 20, 2017 , ... ... to announce that it has been approved for full, active membership in the ... Dallas, Texas, was founded by Chief Executive Officer Jeff Olson in ...
Breaking Biology Technology:
(Date:2/13/2017)... , Feb. 13, 2017 Former 9/11 Commission ... Judiciary Committee, Janice Kephart of Identity Strategy ... Donald Trump,s "Executive Order: Protecting the Nation ... 27, 2017):  "As President Trump,s ,Travel Ban, ... has now essentially banned the travel ban, it is ...
(Date:2/8/2017)... , Feb. 7, 2017 Report Highlights ... The global synthetic-biology ... $11.4 billion by 2021, growing at a compound annual growth ... An overview of the global markets for synthetic biology. - ... for 2016, and projections of compound annual growth rates (CAGRs) ...
(Date:2/7/2017)... 7, 2017 Ipsidy Inc. ( ... [OTC: IDGS], ("Ipsidy" or the "Company") a provider of ... services, is pleased to announce the following changes as ... Effective January 31, 2017, Philip D. Beck ... and President.  An experienced payment industry professional and public ...
Breaking Biology News(10 mins):